| R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions. Endotoxemia contributes to CD27+ memory B-cell apoptosis via enhanced sensitivity to Fas ligation in patients with Cirrhosis
Sci Rep, 2016;6(0):36862.
Species: Human
Sample Type: Plasma
Potential predictive role of chemotherapy-induced changes of soluble CD40 ligand in untreated advanced pancreatic ductal adenocarcinoma
Onco Targets Ther, 2016;9(0):4681-6.
Species: Human
Sample Type: Serum
Involvement of Rac in thromboxane A2induced human platelet activation: regulation of sCD40 ligand release and PDGFAB secretion.
Authors: Kageyama Y, Doi T, Matsushima-Nishiwaki R, Iida Y, Akamatsu S, Kondo A, Kuroyanagi G, Yamamoto N, Mizutani J, Otsuka T, Tokuda H, Iida H, Kozawa O, Ogura S
Mol Med Rep, 2014;10(1):107-12.
Species: Human
Sample Type: Plasma
Inhibition of platelet activation and thrombus formation by adenosine and inosine: studies on their relative contribution and molecular modeling.
Authors: Fuentes E, Pereira J, Mezzano D, Alarcon M, Caballero J, Palomo I
PLoS ONE, 2014;9(11):e112741.
Species: Human
Sample Type: Cell Culture Supernates
Experimental prestorage filtration removes antibodies and decreases lipids in RBC supernatants mitigating TRALI in vivo.
Authors: Silliman C, Kelher M, Khan S, LaSarre M, West F, Land K, Mish B, Ceriano L, Sowemimo-Coker S
Blood, 2014;123(22):3488-95.
Species: Human
Sample Type: Serum
Protective mechanisms of guanosine from Solanum lycopersicum on agonist-induced platelet activation: role of sCD40L.
Authors: Fuentes E, Alarcon M, Astudillo L, Valenzuela C, Gutierrez M, Palomo I
Molecules, 2013;18(7):8120-35.
Species: Human
Sample Type: Platelet Concentrate
Elderly trauma patients have high circulating noradrenaline levels but attenuated release of adrenaline, platelets, and leukocytes in response to increasing injury severity.
Authors: Johansson PI, Sorensen AM, Perner A, Welling KL, Wanscher M, Larsen CF, Ostrowski SR
Crit. Care Med., 2012;40(6):1844-50.
Species: Human
Sample Type: Plasma
Decreased plasma cytokines are associated with low platelet counts in aplastic anemia and immune thrombocytopenic purpura.
J. Thromb. Haemost., 2012;10(8):1616-23.
Species: Human
Sample Type: Serum
Prospective study of circulating soluble CD40 ligand concentrations and the incidence of cardiovascular disease in a nested prospective case-control study of older men and women.
Authors: Jefferis BJ, Whincup PH, Welsh P, Wannamethee SG, Rumley A, Lawlor DA, Ebrahim S, Lowe GD
J. Thromb. Haemost., 2011;9(8):1452-9.
Species: Human
Sample Type: Serum
High sCD40L levels early after trauma are associated with enhanced shock, sympathoadrenal activation, tissue and endothelial damage, coagulopathy and mortality.
Authors: Johansson PI, Sorensen AM, Perner A, Welling KL, Wanscher M, Larsen CF, Ostrowski SR
J. Thromb. Haemost., 2011;10(2):207-16.
Species: Human
Sample Type: Plasma
Pre-operative platelet-bound CD40 ligand is probably associated with peri-operative cardiac events in hip and knee arthroplasty.
Authors: Ray MJ, Calabro LJ, Sirisena T, Crawford SA, Crawford RW, Walters DL
Eur. J. Clin. Invest., 2010;40(6):497-503.
Species: Human
Sample Type: Plasma
Matrix metalloproteinase-9 and plasminogen activator inhibitor-1 are associated with right ventricular structure and function: the MESA-RV Study.
Authors: Kawut SM, Barr RG, Johnson WC
Biomarkers, 2010;15(8):731-8.
Species: Human
Sample Type: Plasma
Platelet turnover, coagulation factors, and soluble markers of platelet and endothelial activation in essential thrombocythemia: relationship with thrombosis occurrence and JAK2 V617F allele burden.
Authors: Arellano-Rodrigo E, Alvarez-Larran A, Reverter JC, Colomer D, Villamor N, Bellosillo B, Cervantes F
Am. J. Hematol., 2009;84(2):102-8.
Species: Human
Sample Type: Plasma
A plant stanol yogurt drink alone or combined with a low-dose statin lowers serum triacylglycerol and non-HDL cholesterol in metabolic syndrome patients.
Authors: Plat J, Brufau G, Dallinga-Thie GM, Dasselaar M, Mensink RP
J. Nutr., 2009;139(6):1143-9.
Species: Human
Sample Type: Plasma
Interleukin-18 is a strong predictor of cardiovascular events in elderly men with the metabolic syndrome: synergistic effect of inflammation and hyperglycemia.
Authors: Troseid M, Seljeflot I, Hjerkinn EM, Arnesen H
Diabetes Care, 2009;32(3):486-92.
Species: Human
Sample Type: Plasma
Soluble CD40 ligand as a biomarker for storage-related preanalytic variations of human serum.
Authors: Lengelle J, Panopoulos E, Betsou F
Cytokine, 2008;44(2):275-82.
Species: Human
Sample Type: Serum
Fish oil in combination with high or low intakes of linoleic acid lowers plasma triacylglycerols but does not affect other cardiovascular risk markers in healthy men.
Authors: Damsgaard CT, Frokiaer H, Andersen AD, Lauritzen L
J. Nutr., 2008;138(6):1061-6.
Species: Human
Sample Type: Serum
Hyperglycemia is associated with enhanced thrombin formation, platelet activation, and fibrin clot resistance to lysis in patients with acute coronary syndrome.
Authors: Undas A, Wiek I, Stepien E, Zmudka K, Tracz W
Diabetes Care, 2008;31(8):1590-5.
Species: Human
Sample Type: Plasma
Plasma concentration of SCUBE1, a novel platelet protein, is elevated in patients with acute coronary syndrome and ischemic stroke.
Authors: Dai DF, Thajeb P, Tu CF, Chiang FT, Chen CH, Yang RB, Chen JJ
J. Am. Coll. Cardiol., 2008;51(22):2173-80.
Species: Human
Sample Type: Plasma
Analysis of platelet alpha2-adrenergic receptor activity in stable coronary artery disease patients on dual antiplatelet therapy.
Authors: Beres BJ, Toth-Zsamboki E, Vargova K, László A, Masszi T, Kerecsen G, Preda I, Kiss RG
Thromb. Haemost., 2008;100(5):829-38.
Species: Human
Sample Type: Plasma
Rosiglitazone produces a greater reduction in circulating platelet activity compared with gliclazide in patients with type 2 diabetes mellitus--an effect probably mediated by direct platelet PPARgamma activation.
Authors: Khanolkar MP, Morris RH, Thomas AW, Bolusani H, Roberts AW, Geen J, Jackson SK, Evans LM
Atherosclerosis, 2007;197(2):718-24.
Species: Human
Sample Type: Serum
Myeloid-related protein 8/14 complex is released by monocytes and granulocytes at the site of coronary occlusion: a novel, early, and sensitive marker of acute coronary syndromes.
Authors: Altwegg LA, Neidhart M, Hersberger M, Muller S, Eberli FR, Corti R, Roffi M, Sutsch G, Gay S, von Eckardstein A, Wischnewsky MB, Luscher TF, Maier W
Eur. Heart J., 2007;28(8):941-8.
Species: Human
Sample Type: Serum
Relationship of soluble CD40 ligand to vascular endothelial growth factor, angiopoietins, and tissue factor in atrial fibrillation: a link among platelet activation, angiogenesis, and thrombosis?
Authors: Choudhury A, Freestone B, Patel J, Lip GY
Chest, 2007;132(6):1913-9.
Species: Human
Sample Type: Plasma
Multiple biomarker use for detection of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome.
Authors: Apple FS, Pearce LA, Chung A, Ler R, Murakami MM
Clin. Chem., 2007;53(5):874-81.
Species: Human
Sample Type: Plasma
No difference in the effects of clopidogrel and aspirin on inflammatory markers in patients with coronary heart disease.
Authors: Solheim S, Pettersen AA, Arnesen H, Seljeflot I
Thromb. Haemost., 2006;96(5):660-4.
Species: Human
Sample Type: Plasma
Humoral and cellular factors responsible for coronary collateral formation.
Authors: Sherman JA, Hall A, Malenka DJ, De Muinck ED, Simons M
Am. J. Cardiol., 2006;98(9):1194-7.
Species: Human
Sample Type: Plasma
Effects of simvastatin on angiogenic growth factors released at the site of microvascular injury.
Authors: Undas A, Celinska-Lowenhoff M, Stepien E, Nizankowski R, Tracz W, Szczeklik A
Thromb. Haemost., 2006;95(6):1045-7.
Species: Human
Sample Type: Plasma
Additive beneficial effects of fenofibrate combined with candesartan in the treatment of hypertriglyceridemic hypertensive patients.
Authors: Koh KK, Quon MJ, Han SH, Chung WJ, Ahn JY, Kim JA, Lee Y, Shin EK
Diabetes Care, 2006;29(2):195-201.
Effects of rosiglitazone alone and in combination with atorvastatin on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus.
Authors: Chu CS, Lee KT, Lee MY, Su HM, Voon WC, Sheu SH, Lai WT
Am. J. Cardiol., 2006;97(5):646-50.
Species: Human
Sample Type: Serum
Relation of improvement in endothelium-dependent flow-mediated vasodilation after rosiglitazone to changes in asymmetric dimethylarginine, endothelin-1, and C-reactive protein in nondiabetic patients with the metabolic syndrome.
Authors: Wang TD, Chen WJ, Cheng WC, Lin JW, Chen MF, Lee YT
Am. J. Cardiol., 2006;98(8):1057-62.
Species: Human
Sample Type: Plasma
|
